ALTAE

FIELD NOTES NUM. 01

ALTAE

The Earth. Recorded. Verified per lot.

Lady with shilajit pouring
Lady with a hammer

Drop 001: Altai shilajit as the first demonstration

SLIDE 02

PROBLEM

  • Shilajit, sold as a premium supplement at $25 to $130 per jar in the US, has documented heavy metal contamination including lead, cadmium, arsenic, mercury, and thallium
  • ConsumerLab's 2024 round on the category found wide variation in active content (fulvic acid) across all eight tested brands; no incumbent leads with verifiable per-lot assay receipts
  • Origin claims default to 'Himalayan' on every label without lot, harvester, altitude, or harvest season disclosed
  • Communities at origin rarely share in upside

The Trust Gap

ORIGINCONSUMERVERIFIABLE DATAStandard Supply ChainALTAE RECORDTHE TRUST GAP

SLIDE 03

INSIGHT

  • 01

    Trust becomes structural when proof is public, specific, and permanent

    A claim is marketing. A public lot record is infrastructure.

  • 02

    Most supplement brands publish a test. ALTAE publishes a record

    Lot, methods, limits, custody, retain sample - linked, not loose.

  • 03

    Connection is continuity from origin to unit

    Each jar resolves to its lot, and that lot resolves to its evidence.

  • 04

    A repeatable disclosure standard scales beyond shilajit

    Shilajit is the entry point. The system applies across origins and categories.

Drop rule: No result, no drop.

LEDGER ANATOMY

UNIT

QR on jar

Lot ID on label

LOT PAGE

altae.earth/ledger/LOT A001

Status: Pending, Verified...

EVIDENCE PACK

COA PDF

Methods summary

Limits and pass fail

Sampling note

TRACE

Chain of custody log

Handling steps

Retain sample record

INTEGRITY

File fingerprint for COA

Version history

Timestamped update log

RELEASE GATE

Evidence required

SLIDE 04

SOLUTION

A technical record of proof plus an atlas of origin.

  • 01 VERIFICATION

    ICP-MS heavy metals per EPA Method 6020B (LOD 0.08 ppb, NIST SRM 2711a-validated). HPLC-UV fulvic acid quantification per ICH Q2(R2) (RSD ≤2.0%, PDA spectral overlay, forced degradation). Per-lot uncertainty budgets per ISO/IEC 17025:2017 Clause 7.6.3. Mass-balance modelling per dose.

  • 02 DOCUMENTATION

    Origin is not a claim. It is documented with consent through local partners, field notes, and recorded context tied to the lot record.

  • 03 RECIPROCITY

    Connection returns to the buyer and the community. Buyers can see what is real, and can vote on where a portion of each drop returns through community selected projects.

  • 04 REPEATABILITY

    This is a repeatable system across the world. Shilajit is Drop 001. The product is the standard and the record.

Bottom line:

Release rule: No result, no drop.

ATLAS OF ORIGIN

Public Record by Drop

World Map

DROP 001 MONGOLIA ALTAI

PUBLIC LOT RECORD

LOT A001

  • COA PDF
  • METHODS AND LIMITS
  • CHAIN OF CUSTODY NOTES
  • RETURN RECEIPT

DROP 002 CENTRAL ASIA

DROP 003 HIMALAYAN FOOTHILLS

DROP 004 ANDES HIGHLANDS

DROP 005 ATLAS RANGE

DROP 006 SAHARA OASIS

VERIFICATIONLOT TESTS PUBLIC
DOCUMENTATIONORIGIN RECORDED
RECIPROCITYRETURN RECEIPT
REPEATABILITYSAME STANDARD

SLIDE 05

THE ALTAE ENGINE

A repeatable system for origin based drops. Proof gates release. Each drop strengthens the standard.

  • 01

    Inputs

    Origin partner, consent, context, raw material, custody artifacts.

  • 02

    Proof Gate

    Independent testing per lot. Identity plus contaminants. No pass, no release.

  • 03

    Public Record

    Lot page, COA, methods, limits, custody, retain sample.

  • 04

    Drop Mechanics

    Limited batch release. Waitlist allocation. Price integrity through scarcity plus proof.

  • 05

    Return Loop

    Value flows back. Receipt published. Standard updated.

Shilajit is the entry point. The system scales across origins and categories.

INPUTS

  • Origin partner
  • Consent and context
  • Raw material
  • Traceability artifacts
  • Retain sample

PROOF GATE

Gate 01 Identity
Gate 02 Contaminants
Gate 03 Spec limits

RELEASE RULE

No result, no drop

ENGINE OUTPUT PER DROP

Lot page + COA + trace artifacts

OUTPUTS

  • Public COA
  • Lot page and ledger
  • QR to evidence
  • Limited drop release

RETURN LOOP

Partner payoutPublished receiptStandard v1 updated

PROOF BUNDLE (IMMUTABLE)

HASH
TIMESTAMP
SIGNATURES
STORAGE
CHAIN
VERIFY
*HASH: SHA-256 fingerprint*TIMESTAMP: Signed receipt*SIGNATURES: Document integrity*STORAGE: IPFS pinned*CHAIN: Polygon/Base*VERIFY: Hash match

SLIDE 06

WHY DROP 001 IS SHILAJIT

  • 01Customer discovery (n=15 amateur athletes and Function Health users at a New York run club) confirms a clear buyer profile: the biohacker reader who treats third-party CoA testing as their primary supplement evaluation criterion
  • 02The buyer splits two ways. Aware of shilajit with heavy-metal concerns. Unaware of the category but willing to try if testing is verifiable
  • 03The category has rising interest (US shilajit market $32M today, $50M projected by 2030 at 9.3% CAGR per Grand View Research) and no premium incumbent leads with verifiable assay receipts
  • 04Once the engine exists, adding new drops has lower marginal cost
Geological terrain map of Altai region
Terrain relief overview

LOCATION

Bayan-Ölgii Province, Western Mongolia

SLIDE 06.5

WHO BUYS

The biohacker reader, in two sub-segments.

  • 01

    Aware buyer

    Already takes shilajit. Has heavy-metal concerns. Reads ConsumerLab, Examine.com, Oasis Health-style purity scanners. Buys Cymbiotika, Pure Himalayan, Pürblack today and switches to whoever has the cleanest receipts.

  • 02

    Unaware buyer

    Does not currently take shilajit but trusts the testing-first frame. Reads Huberman Lab, Peter Attia (Outlive), Bryan Johnson's Blueprint protocol. Already on Function Health or InsideTracker. Will try a new category if verification is published.

  • 03

    Both share a trust mechanism

    Third-party CoA, named labs, public assay data. They use the same filter to evaluate every supplement they take. ALTAE's Ledger page is built for that filter.

  • 04

    Common-mode demographics

    Men 30-50, urban or suburban US, household income $80K+, already on 5-15 supplements, references the same authority set.

SLIDE 07

PRODUCT EXPERIENCE

  • 01Landing page with brand story and transparency positioning
  • 02Ledger index with all published lots
  • 03Lot page with COA, chain log, and origin documentation
  • 04Story page with origin films and narrative
  • 05Waitlist and drop access flow

The product is the public record plus the drop

Lot Detail Page

Lot Detail Page

Ledger Index

Ledger Index

Origin Story

Origin Story

Artifacts & Lab Panels

Artifacts & Lab Panels

SLIDE 08

MARKET

Shilajit alone is not a venture-scale business. Shilajit is the wedge that earns altae the right to attempt the platform.

01 WEDGE CATEGORY (US SHILAJIT)

$50M

Source: Grand View Research, US Shilajit Market Outlook 2025-2030.

02 ADJACENT CATEGORIES (PROOF-LED EXPANSION)

$2-4B

Source: Triangulated from Grand View, Mordor Intelligence, ConsumerLab category reports.

03 PLATFORM CEILING

$24.9B

Source: IBISWorld, Online Vitamin & Supplement Sales in the US.

SIZING LOGIC

TAM: Wellness is a broad spend category with recurring purchase behavior.

SAM: US online vitamins & supplements—the DTC channel we can reach efficiently.

SOM: US shilajit base × online share × premium share × target penetration.

Share assumptions flagged as internal and testable via early CAC + conversion data.

TAM $161.7BGlobal WellnessSAM $24.9BUS Online SupplementsSOM$13MSubscription • Strong margin • High repeat • Trust differentiator

SLIDE 09

COMPETITION

Premium incumbents lead on aesthetic. Budget incumbents lead on dose-precision. No US shilajit brand pairs metrology completeness with documented harvest. ALTAE sits in the unowned quadrant.

  • 01

    What the map measures

    X axis: Proof transparency (private or vague COAs at left, public lot-level COA at right). Y axis: Origin documentation (generic sourcing at bottom, traceable place plus context at top).

  • 02

    Premium / lifestyle (top-left)

    Cymbiotika. $130 per 200 servings. Aesthetic-led. CoA in policy pages, not on product surface.

  • 03

    Mid-tier proof leader (top-right, alongside ALTAE)

    Pure Himalayan Shilajit. Publishes ICP-MS chromatograms with calibration logs and NIST SRM 2711a comparability. Retail-scale proof, but no per-lot uncertainty budgets and no harvest specificity.

  • 04

    Budget / standardised extract (bottom)

    Nootropics Depot PrimaVie. $0.19 per dose. Patented extract with disclosed actives, no provenance.

  • 05

    ALTAE wedge

    Per-lot uncertainty budgets, GPS-stamped harvest, diaspora cultural translation, drop mechanic. Pure Himalayan publishes proof at retail scale; altae publishes proof with metrology completeness Pure Himalayan does not yet match.

PRIVATE COAPUBLIC LOT COAPROOF TRANSPARENCY →GENERICTRACEABLEORIGIN DOC →Generic AmazonPremium BrandsDTC WellnessAyurvedic ImportsLab-Tested NicheAALTAEThe Wedge

SLIDE 10

BUSINESS MODEL

01 DROPS MODEL

$89

15g resin jar, DTC, domestic shipping included

Limited batch releases with public lot proof

Shilajit is the entry point; the repeatable system is the product

02 VARIABLE COST (ex testing)

$21

Resin, Packaging, Fulfillment, Processing, Ledger/Ops

Product + pack = $11.20; remainder is fulfillment + payments + ledger ops

Resin $8.00 + Pack $3.20 = $11.20; Fulfillment $6.00 + Processing $2.10 + Ledger/ops $1.70 = $9.80

03 TESTING (Alkemist)

$2,000

Per lot. Lot size 1,000 jars. Amortized $2.00 per jar

04 MARGIN

76%

Contribution profit $68 per jar (ex testing)

Including testing amortization: $66.00 per jar, 74%

SLIDE 11

REVENUE

Drops are the revenue unit. Each Drop is one tested lot with one public record.

ASSUMPTIONS

  • Price per unit$69
  • Variable unit cost$21
  • Testing per lot (Alkemist)$2,000
  • Contribution profit (after testing) = Units × (Price − Variable cost) − Testing per lot

Testing is fixed per lot and improves unit economics as lots scale.

Testing amortization: $2.00 → $0.80 per unit as lots scale (Drops 1–4).

DROP 001

1,000 units

Revenue

$69,000

Contribution Profit (After Testing)

$46,000

DROP 002

1,500 units

Revenue

$103,500

Contribution Profit (After Testing)

$70,000

DROP 003

2,000 units

Revenue

$138,000

Contribution Profit (After Testing)

$94,000

DROP 004

2,500 units

Revenue

$172,500

Contribution Profit (After Testing)

$118,000

12 MONTH

7,000 units

Total Revenue

$483,000

Total Contribution (After Testing)

$328,000

~68% margin

CUMULATIVE BY DROP

$500k$250k$0DROP 001DROP 002DROP 003DROP 004RevenueContribution

Contribution profit = Revenue - Variable cost ($21) - Testing ($2,000/lot). Excludes paid marketing, returns, chargebacks.

SLIDE 12

TRACTION

Signal captured. Proof gated. Deposit next.

WAITLIST

898

3 months, organic and referral

VERIFIED COMMITMENTS

567

Email confirmed, COA contingent

DEPOSIT VALIDATION

NEXT

Small deposit hold to validate paid demand

PROOF STATUS

Sample received and retain sample logged

Alkemist testing underway

Origin partner and consent secured

Media edits complete and ready to publish

Ledger and waitlist live at altae.earth

INTENT SIGNAL

63%

Metrics as of Jan 2026

SLIDE 13

FOUNDERS

Haamid Adam

Haamid Adam

FOUNDING PARTNER

haamid@altae.earth

  • Chartered Engineer and MIT Sloan MBA
  • Built Roomeru.com, a student first housing platform
  • Co founding Thermolytic Materials, an MIT MechE lab spinout
  • Built trust and compliance systems in regulated global supply chains across Japan, Korea, Taiwan, and the UK with SIEMENS.
  • Cultural ties to South Asia and the Middle East
  • Leads ALTAE's proof system, ledger, supply chain controls, and media direction
  • Worked in the West Coast VC ecosystem with DCVC, bringing a systems approach to trust, provenance, and quality

PLACEHOLDER

Quentin Millette

COFOUNDER

Qm1@umd.edu

  • PhD candidate at the University of Maryland [PLACEHOLDER: discipline]
  • Authored the April 2026 shilajit category research that informs ALTAE's positioning, market sizing, and buyer profile
  • [PLACEHOLDER: prior research, publications, or ventures]
  • [PLACEHOLDER: domain remit at ALTAE - e.g. research, scientific advisory, supply chain]
  • [PLACEHOLDER: personal angle - cultural ties, lived experience, motivation]
We build origin based drops where trust is published, not promised. Shilajit is the entry point, the repeatable system is the product.

SLIDE 14

ROADMAP & USE OF FUNDS

MILESTONES

By May 11Lot A001 evidence bundle live (FTIR + thallium added to existing CoA), Ledger page published, IPFS pinned, Polygon anchored
By May 18v1.4.1 CoA published: RSD tightened to ≤2.0% per ICH Q2(R2) Annex II; expanded uncertainty (k=2) on GPS timestamping per ISO/IEC 17025:2017 Clause 7.8.2; tagged outreach to one named supplement-quality researcher for independent endorsement
May 11-25Channel-segmented conversion test on biohacker channels (Huberman-adjacent newsletter, biohacker Substack, paid LinkedIn). Cost-per-waitlist-signup measured per channel
May 25-June 1Waitlist-to-pre-order test at the $89 Drop 001 price point
By June 1Validation decision: continue with follow-on capital request, or stop and salvage brand and Ledger as durable assets
June-JulyIf validation positive: LLC formation, USPTO trademark Class 5, FDA facility registration, FSVP filing, Drop 002 commercial import sourcing
August-SeptemberDrop 002 ships under compliant import. Second region or second category options on the table

USE OF FUNDS

FTIR identity verification on Lot A001 (Alkemist)$400
Thallium ICP-MS add-on on Lot A001 (Alkemist)$150
ALTAE LLC, Wyoming (Northwest Registered Agent)$150
USPTO trademark Class 5, TEAS Plus$250
Pinata IPFS pinning, annual Pro tier$240
Polygon / Base gas budget for Lot A001 + spare for Lot A002$30
Contingency / overrun buffer$80
MIT SANDBOX TOTAL (REMAINING)$1,300
GAP TO DROP 002 (FSVP, broker, insurance, per-lot testing)$5,000 - $11,000

APPENDIX A1

WHAT THE LEDGER PROVES IN PLAIN ENGLISH

The ledger makes integrity failures visible and therefore costly.

NO CHERRY PICKING

These artifacts belong to this lot.

LOTCOA001002003001002003

Cross lot reuse fails verification

  • The manifest binds COA, panels, custody notes, and origin assets to one lot ID
  • Reusing best looking files across lots breaks verification

NO SILENT CHANGES

Evidence cannot be quietly swapped.

ARTIFACT
RECORDED
RECOMPUTED
STATUS
COA
9f3a1c4d
9f3a1c4d
MATCH
Heavy M.
c21e8a10
c21e8a10
MATCH
Microbio
54b0d91a
54b0d91a
MATCH
Photos
aa83f0b9
f19c2d77
MISMATCH

Any swap changes the fingerprint

  • Every file has a fingerprint. Change the file and the fingerprint changes
  • Any mismatch is visible to anyone verifying, not only ALTAE

NO HISTORY REWRITES

You cannot rewrite the record after publishing.

PUBLISHRECEIPTVERIFYANCHORIMMUTABLE

Once anchored, history cannot be rewritten

  • Publish time is recorded and receipts are signed at publication
  • Chain anchoring later makes the publish time externally immutable

ALTAE does not ask for trust. It makes trust checkable.

APPENDIX A2

HOW THE PHYSICAL WORLD TOUCHES THE LEDGER

Hashes prove file integrity. Controls link the tested sample to the lot shipped.

PHYSICAL

LEDGER

LOT ID AND SEAL

Lot ID applied to containers plus tamper seal on every unit

Lot created event plus unit level lot ID recorded

SAMPLE DRAW

Sample pulled from the lot, sealed, labeled, photographed

Sample draw record plus seal photo added as artifacts

SHIP TO LAB

Tracked shipment to lab with tamper intact packaging

Lab shipped event plus tracking number and timestamp

LAB INTAKE AND COA

Lab assigns intake ID and returns COA for the received sample

Lab intake recorded plus COA PDF fingerprint published

PUBLISH AND RETAIN

Retain sample archived for challenge retest

Bundle created, receipt signed, publish event, retain log artifact

Ledger integrity plus physical controls closes the gap between evidence and inventory.

APPENDIX A3

WHAT WE MEAN BY 'IT MAKES FALSIFICATION EXPENSIVE'

The system raises the cost of cheating by raising the probability of detection.

DETECTIONACCOUNTABILITYCONSEQUENCEFALSIFICATIONBECOMES EXPENSIVE

DETECTION

  • Swapped PDFs and images create fingerprint mismatches
  • Cross lot reuse becomes visible in the manifest structure
  • Verification is independent and repeatable

ACCOUNTABILITY

  • Append only events create a public timeline per lot
  • Signed receipts show what existed and when
  • Updates must be explicit rather than silent replacements

CONSEQUENCE

  • Mismatch is a public integrity signal
  • Trust failure becomes measurable rather than arguable
  • Brands cannot rely on ambiguity

This is a proof system, not a branding claim.

APPENDIX A3.1

THE TRUST TAX

When proof is checkable, ambiguity becomes a measurable operating cost.

COST OF AMBIGUITY

  • 01 TRUST DISCOUNT

    Claims you cannot check get discounted. Conversion drops or price must drop.

  • 02 CAC INFLATION

    Without proof, marketing must fund persuasion: education, reassurance, testimonials, discounting.

  • 03 PUBLIC FAILURE MODE

    When evidence is checkable, a mismatch becomes a visible integrity event, not an argument.

Proof reduces the spend required to overcome skepticism.

CAC PER ORDER UNDER "PROOF EXPECTED" CONDITIONS

Illustrative model using ALTAE unit economics. Not measured.

$25

Verification UX$3
Education$4
Base acquisition$18

ALTAE PROOFED

Contribution after CAC

$23

TRUST TAX

+$20

$45

$7Discounting
$8Reassurance
$12Persuasion
$18Base acquisition

NO PROOF BRAND

Contribution after CAC

$3

Contribution before CAC = $69 − $21 = $48. Trust tax is modeled as CAC inflation from persuasion and discounting.

APPENDIX C1

EVIDENCE BASE

Three sources triangulate. None alone is definitive; together they constrain the wedge.

TRIANGULATION

PMRn=15SCENARIO213 rdsMARKET3rd-partyWEDGEDEFINED

Three sources constrain the wedge.
None alone is definitive.

01

PRIMARY MARKET RESEARCH

n=15 in-person interviews, NYC run club, Q1 2026

  • Cohort: amateur athletes and Function Health users
  • Recorded; willingness-to-pay and trigger-to-purchase questions asked directly
  • Buyer profile identified: biohacker reader who treats third-party CoA testing as primary supplement evaluation criterion
  • Two sub-segments emerged: aware shilajit buyers with heavy-metal concerns, unaware buyers who would try if testing was verifiable
02

AGENT-BASED SCENARIO MODELLING

27 archetypal agents, dual-platform, 213 rounds, Q2 2026

  • Reality seed grounded in published market data plus the n=15 PMR; structured prior, not primary research
  • Agents include 6 buyer sub-segments, 5 named brands as active actors, 12 media channels and trust authorities
  • Output: PMR directionally confirmed; wedge sharpened from 'transparency' to 'metrology compliance'; on-chain framing flagged as repellent to primary buyer
  • Highest-engagement entity in the run was the PMC11743217 thallium study, not any altae post
03

PUBLISHED MARKET DATA

Third-party reports cross-referenced

  • US shilajit category $32M today, $50M by 2030 at 9.3% CAGR (Grand View Research)
  • ConsumerLab 2024 round on 8 brands found wide variation in fulvic acid concentration; no incumbent reports per-lot quantification on product surface
  • PMC11743217 (2024): 65 heavy metals across commercial shilajit samples; thallium exceeding WHO guidance in 37% of tested batches

APPENDIX C2

WHO BUYS - SUB-SEGMENTS WITH EVIDENCE

Conversion mechanism differs by buyer; one-size-fits-all positioning fails.

BUYER QUADRANT

METROLOGY-LEDCULTURAL-LEDCONVERTIBLE 2026UNCOVERABLE 2026BIOHACKERDOMINANTDIASPORACONVERTIBLEPROVENANCENICHEGENERALDROP 003+

Dot size = priority for Drop 001-002.

01

BIOHACKER (DOMINANT)

  • Trusts third-party CoA, named labs, Huberman Lab, Peter Attia, Function Health, Oasis Health
  • Decision driver: reproducible metrology
  • Repels on-chain framing as headline; accepts it as container
  • Repels brand voice; rewards methodology language
  • Price-band: $80-$120 jar
02

DIASPORA AYURVEDIC

  • Initially repelled by digital provenance ('Real provenance isn't hashed')
  • Converts on cultural artifacts: Nepali audio harvester notes, harvester-signed affidavits, GPS-verified collection zones, 'rasayana as relationship'
  • Decision driver: cultural alignment plus quality
  • Currently underserved by altae's brand world
  • High repeat-purchase rate once converted
03

PROVENANCE CONSUMER

  • Origin specificity, harvest narrative, the maker's story
  • Reads FT Weekend, Air Mail, Monocle, niche craft Substacks
  • Accepts dual-layer model: technical record plus origin documentation
  • Decision driver: story plus place
  • Brand-loyal once converted
04

GENERAL WELLNESS (UNCOVERABLE 2026)

  • Sensory familiarity, brand recognition, retail availability
  • $29.99 (Pure Himalayan) is the price anchor; $89 is rejected without taste familiarity
  • Whole Foods / Amazon presence is trust proxy
  • Drop 003 / 004 segment once altae has retail incumbency, not Drop 001

altae's brand build is correctly aimed at the biohacker buyer. The diaspora sub-segment is convertible but requires cultural translation altae does not yet produce.

APPENDIX C3

THE COMPLIANCE STACK

Specific standards altae conforms to, by panel.

ALTAE COMPLIANCE STACK

5 PANELS

Physical
Ledger / Standard
L5

ICP-MS HEAVY METALS

Lead, Cadmium, Arsenic, Mercury, AND Thallium per lot. LOD 0.08 ppb
EPA Method 6020B; NIST SRM 2711a validation; raw chromatograms IPFS-pinned
L4

HPLC-UV FULVIC ACID

Per-lot active concentration in mg/g, with PDA spectral overlay across batches
ICH Q2(R2) Annex II compliant: RSD ≤2.0% retention time, resolution ≥2.0, forced degradation, system suitability
L3

GPS-STAMPED HARVEST

±15m elevation, ±30s timestamp, mapped against traditional land-use boundaries
Expanded uncertainty (k=2) per ISO/IEC 17025:2017 Clause 7.8.2; documented calibration
L2

MASS-BALANCE MODELLING

Per-dose accountability for trace contaminants
0.12 µg/day Tl @ 250 mg dose calculated and published per lot
L1

MICROBIAL PANEL

Total aerobic count, yeasts, moulds, pathogen panel
USP <2021>/<2022> compliant

PHYSICAL WORLD

v1.4 CoA in production; v1.4.1 (RSD ≤2.0%, GPS expanded uncertainty) targeted by May 18.

APPENDIX C4

DIASPORA CONVERSION PATH

How a sub-segment that initially rejects altae's brand world is won over.

CONVERSION JOURNEY

01REJECT

Initial rejection

'Real provenance isn't hashed - it's handed down. Show me the family who harvested it, not the smart contract.' (Diaspora persona, scenario modelling, April 2026)

02AUDIO

Conversion mechanism #1 - Nepali audio harvester logs

Recorded field notes from Kumaon and Altai harvesters, Nepali language with English transcript toggle, timestamped and IPFS-pinned, embedded above the fold on the product page

03AFFIDAVIT

Conversion mechanism #2 - Harvester-signed affidavits

Physical document signed by the named harvester per lot, photographed and linked to the lot's Ledger page, alongside GPS-verified collection zones mapped against traditional land-use boundaries

04FRAMING

Conversion mechanism #3 - Cultural framing

'Rasayana as relationship: between body, land, lab, and lineage' - the dual-layer narrative that holds technical rigor and cultural continuity together rather than substituting one for the other

05CONVERTED

Resulting disposition shift

Post-conversion, the dual-layer model resolves the 'hygiene vs. hype' tension that initially rejected the brand

INITIAL REJECTION

CULTURAL ARTIFACTS BUILD TRUST

DUAL-LAYER RESOLVES TENSION

These artifacts are not yet produced. Drop 002 budget should fund their production (~$500-1,500).

01 / 23